HIGHLIGHTS
- who: Mengqin Yuan from the (UNIVERSITY) have published the research: Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease, in the Journal: (JOURNAL)
SUMMARY
Viral and alcoholic liver disease, drug-induced liver disease, autoimmune hepatitis, and primary biliary cirrhosis can eventually progress to end-stage liver disease, which has gradually become one of the main causes of death globally. Multiple therapeutics have been developed to target end-stage liver disease, including drugs, artificial livers, and endoscopic and vascular interventions for portal hypertension. Currently, orthotopic liver transplantation remains the only effective treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.